Related Experiment Video
Updated: Jun 3, 2026
06:50
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
[The comparison study between UniCAP EliA and former kit for measuring the autoantibodies]
Ritsuko Nagatomo1, Naomi Watanabe, Shigeo Okubo
1Department of Clinical Laboratory, The University of Tokyo Hospital, Bunkyo-ku, Tokyo 113-8655, Japan. nagatomo-dis@h.u-tokyo.ac.jp
Rinsho Byori. the Japanese Journal of Clinical Pathology
|March 17, 2011
Summary
The UniCAP EliA assay demonstrates superior reproducibility for diagnosing autoimmune diseases compared to the MESACUP method. While concordance varies for specific autoantibodies, UniCAP EliA shows promise for routine clinical use.
Area of Science:
- Clinical Immunology
- Autoimmune Disease Diagnostics
- Immunoassay Technology
Background:
- Autoantibody measurements are crucial for diagnosing autoimmune diseases.
- Current diagnostic methods include ELISA-based assays like MESACUP.
- Evaluating new immunoassay platforms is essential for improving diagnostic accuracy and efficiency.
Purpose of the Study:
- To compare the performance of the UniCAP EliA fluorescence-enzyme immunoassay with the MESACUP ELISA method.
- To assess the reproducibility and concordance of autoantibody measurements between the two platforms.
- To determine the clinical utility of UniCAP EliA for routine autoimmune disease diagnosis.
Main Methods:
- A total of 404 sera were analyzed using both UniCAP EliA on the UniCAP 250 instrument and MESACUP assays.
- Within-day and between-day reproducibility were evaluated by calculating coefficients of variation (CVs).
- Concordance analysis was performed for various autoantibodies, including U1RNP, SS-A/Ro, SS-B/La, Scl-70, Jo-1, dsDNA, and Sm.
Main Results:
- UniCAP EliA exhibited better within-day (3.0-9.6%) and between-day (1.0-11.8%) reproducibility compared to MESACUP (1.7-11.7% and 1.0-19.9%, respectively).
- High concordance (89.5-100%) was observed for U1RNP, SS-A/Ro, SS-B/La, Scl-70, and Jo-1.
- Lower positive concordance was noted for dsDNA, Sm, and Jo-1 (40.0-62.9%), indicating potential discrepancies.
Conclusions:
- UniCAP EliA demonstrates superior reproducibility over the MESACUP method for autoantibody testing.
- Discrepant results between the methods may stem from antigen purification or assay principles.
- UniCAP EliA's performance suggests its suitability and high clinical importance for routine autoimmune disease diagnostics.
